Product liability for medicinal pharmaceuticals in Germany
Pharmaceuticals Policy and Law · 2018-12 · 20 (1-4) · 103-114
DOI: 10.3233/ppl-180470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals Policy and Law, 2018-12. Verfasst von Ulrich Magnus.
Abstract (Originalsprache)
In 1976 Germany introduced a special strict liability regime for personal injuries through pharmaceuticals for human consumption. This was in reaction to the Thalidomide-catastrophe in the 1950ies and 1960ies. Since then, Germany disposes of a two lane-system of liability in this field: traditional fault liability under general tort law and strict liability under the special Medicinal Products Act. The following article examines in detail the conditions of liability under either regime. Also, possible defences and procedural matters are being dealt with as well as the question of insurance and the accessibility of funds established for victims.
Zitieren
APA
Magnus, U. (2018). Product liability for medicinal pharmaceuticals in Germany. Pharmaceuticals Policy and Law, 20(1-4), 103-114. https://doi.org/10.3233/ppl-180470
Vancouver
Magnus U. Product liability for medicinal pharmaceuticals in Germany. Pharmaceuticals Policy and Law. 2018;20(1-4):103-114. doi:10.3233/ppl-180470
BibTeX
@article{Magnus2018,
author = {Magnus, Ulrich},
title = {Product liability for medicinal pharmaceuticals in Germany},
journal = {Pharmaceuticals Policy and Law},
year = {2018},
volume = {20},
number = {1-4},
pages = {103--114},
doi = {10.3233/ppl-180470}
}
EUVIMED